Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 21.7.2023TEVA Pharmaceuticals Slovakia s.r.o. (TEV-SK)43877VEROGALID ER 240 mg (tbl plg 30x240 mg (liek.PE))27.7.2023O
 20.7.2023BB Pharma a.s. (BBP-CZ-1)34846BITAMMON (plv sus 1x70 ml/3,5 g (fľ.tmavá))20.7.2023O
 20.7.2023Takeda Manufacturing Austria AG (TKM-5)32330ADVATE 250 IU prášok a rozpúšťadlo na injekčný roztok (plv iol 1x250 IU+1x2 ml solv. (liek.inj.skl.+liek.inj.skl.+ pom.na rekonšt.))1.8.2023Z
 20.7.2023Takeda Manufacturing Austria AG (TKM-5)32332ADVATE 1000 IU prášok a rozpúšťadlo na injekčný roztok (plv iol 1x1000 IU+1x2 ml solv. (liek.inj.skl.+liek.inj.skl.+ pom.na rekonšt.))1.8.2023Z
 20.7.2023Takeda Manufacturing Austria AG (TKM-5)40831ADVATE 250 IU prášok a rozpúšťadlo na injekčný roztok (plv iol 1x250 IU+1x5 ml solv. (liek.inj.skl.+liek.inj.skl.+ pom.na rekonšt.))1.8.2023Z
 20.7.2023Takeda Manufacturing Austria AG (TKM-5)40832ADVATE 500 IU prášok a rozpúšťadlo na injekčný roztok (plv iol 1x500 IU+1x5 ml solv. (liek.inj.skl.+liek.inj.skl.+ pom.na rekonšt.))1.8.2023Z
 20.7.2023Takeda Manufacturing Austria AG (TKM-5)40833ADVATE 1000 IU prášok a rozpúšťadlo na injekčný roztok (plv iol 1x1000 IU+1x5 ml solv. (liek.inj.skl.+liek.inj.skl.+ pom.na rekonšt.))1.8.2023Z
 20.7.2023Noridem Enterprises Ltd. (NID)4254DMetronidazole Noridem 5 mg/ml infúzny roztok (sol inf 10x100 ml (fľ.PP-utesnenie twin port))20.7.2023O
 20.7.2023Noridem Enterprises Ltd. (NID)4255DMetronidazole Noridem 5 mg/ml infúzny roztok (sol inf 20x100 ml (fľ.PP-utesnenie twin port))20.7.2023O
 20.7.2023Noridem Enterprises Ltd. (NID)6921DBupivacaine Noridem 5 mg/ml injekčný roztok (sol inj 10x20ml/100 mg (amp.PP))20.7.2023U
 20.7.2023ARDEZ Pharma, spol. s r.o. (ARZ)0551DDutamon (cps mol 90x0,5 mg (blis.PVC/PE/PVDC/Al))24.7.2023R
 20.7.2023B.Braun Melsungen AG (BME)0019AParacetamol B. Braun 10 mg/ml (sol inf 10x100 ml/1000 mg (fľ.LDPE))20.7.2023O
 20.7.2023Adamed Czech Republic s.r.o. (AAZ)33579SERLIFT 100 mg (tbl flm 30x100 mg)19.6.2023R
 19.7.2023Exeltis Slovakia s.r.o. (EET)2051BVELBIENNE 2 mg/1 mg filmom obalené tablety (tbl flm 3x28 (blis.PVC/PVDC/Al))19.7.2023R
 19.7.2023Bayer, spol. s r.o. (BAY-SK-2)17890Claritine 10 mg (tbl 10x10 mg (blis.Al/PVC))19.7.2023O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)